NCT01736254View on ClinicalTrials.gov

A Study of Evacetrapib in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Healthy Volunteers
Interventions
DRUG

Evacetrapib

DRUG

Gemfibrozil

Trial Locations (1)

32117

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Daytona Beach

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01736254 - A Study of Evacetrapib in Healthy Participants | Biotech Hunter | Biotech Hunter